Selective estrogen receptor modulators and coronary heart disease

Area of Science:

• Cardiovascular Science
• Endocrinology
• Pharmacology

Background:

• Estrogen influences vasculature via rapid non-genomic and classic genomic pathways involving estrogen receptors (ER-alpha and ER-beta).
• Estrogen-controlled genes offer diverse therapeutic targets for drug development, including selective estrogen receptor modulators (SERMs).

Purpose of the Study:

• To review recent advances in understanding estrogen receptor (ER) and ligand actions.
• To explore therapeutic implications of ER modulation for coronary heart disease (CHD).
• To highlight clinical and basic research progress on cardiovascular protection by ERs/SERMs.

Main Methods:

• Review of recent clinical and basic studies on estrogen receptor actions.
• Analysis of selective estrogen receptor modulators (SERMs) and their applications.
• Discussion of laboratory investigations into ER/ligand interactions and cardiovascular effects.

Main Results:

• Estrogen receptors play a significant role in cardiovascular health, though precise protective mechanisms are still under investigation.
• Selective estrogen receptor modulators (SERMs) are being developed to target specific estrogenic effects, aiming for cardiovascular benefits while minimizing risks.
• Recent studies show progress in understanding ER/ligand interactions and their therapeutic potential for coronary heart disease.

Conclusions:

• Estrogen receptors are crucial targets for managing cardiovascular diseases.
• Selective estrogen receptor modulators (SERMs) represent a promising therapeutic strategy for coronary heart disease (CHD) and related conditions.
• Further research into ER/ligand interactions and SERM development is essential for optimizing cardiovascular protection.